JP2010506910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010506910A5 JP2010506910A5 JP2009533278A JP2009533278A JP2010506910A5 JP 2010506910 A5 JP2010506910 A5 JP 2010506910A5 JP 2009533278 A JP2009533278 A JP 2009533278A JP 2009533278 A JP2009533278 A JP 2009533278A JP 2010506910 A5 JP2010506910 A5 JP 2010506910A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- quinolin
- ylidene
- piperidin
- benzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 208000019901 Anxiety disease Diseases 0.000 claims description 2
- 230000036506 anxiety Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- UIUHRTMSQIPPSU-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-methyl-4-[piperidin-4-ylidene(quinolin-8-yl)methyl]benzamide Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(C=1C2=NC=CC=C2C=CC=1)=C1CCNCC1 UIUHRTMSQIPPSU-UHFFFAOYSA-N 0.000 claims 10
- YHZOSVOJWLWTLC-UHFFFAOYSA-N 4-[bromo(piperidin-4-ylidene)methyl]-n-(2-hydroxyethyl)-n-methylbenzamide Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(Br)=C1CCNCC1 YHZOSVOJWLWTLC-UHFFFAOYSA-N 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- KXJJSKYICDAICD-UHFFFAOYSA-N quinolin-8-ylboronic acid Chemical compound C1=CN=C2C(B(O)O)=CC=CC2=C1 KXJJSKYICDAICD-UHFFFAOYSA-N 0.000 claims 4
- -1 (4- (N- (2-hydroxyethyl) -N-methylcarbamoyl) phenyl) (quinolin-8-yl) methylene Chemical group 0.000 claims 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 3
- ZJKUETLEJYCOBO-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-methyl-4-[quinolin-8-yl-[1-(1,3-thiazol-4-ylmethyl)piperidin-4-ylidene]methyl]benzamide Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(C=1C2=NC=CC=C2C=CC=1)=C1CCN(CC=2N=CSC=2)CC1 ZJKUETLEJYCOBO-UHFFFAOYSA-N 0.000 claims 3
- WRFKSVINLIQRKF-UHFFFAOYSA-N 1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC=N1 WRFKSVINLIQRKF-UHFFFAOYSA-N 0.000 claims 2
- VXFBDZNSWXGHHU-UHFFFAOYSA-N 4-[bromo(piperidin-4-ylidene)methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(Br)=C1CCNCC1 VXFBDZNSWXGHHU-UHFFFAOYSA-N 0.000 claims 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 2
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 claims 2
- KWSAVZDIBRTUEI-UHFFFAOYSA-N tert-butyl 4-[[4-[2-hydroxyethyl(methyl)carbamoyl]phenyl]-quinolin-8-ylmethylidene]piperidine-1-carboxylate Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(C=1C2=NC=CC=C2C=CC=1)=C1CCN(C(=O)OC(C)(C)C)CC1 KWSAVZDIBRTUEI-UHFFFAOYSA-N 0.000 claims 2
- LRCHQJMBFAIMEU-UHFFFAOYSA-N tert-butyl 4-[bromo-[4-[2-hydroxyethyl(methyl)carbamoyl]phenyl]methylidene]piperidine-1-carboxylate Chemical compound C1=CC(C(=O)N(CCO)C)=CC=C1C(Br)=C1CCN(C(=O)OC(C)(C)C)CC1 LRCHQJMBFAIMEU-UHFFFAOYSA-N 0.000 claims 2
- ZXAPQWICZVMRRE-UHFFFAOYSA-N 4-[bromo-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-ylidene]methyl]benzoic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1=C(Br)C1=CC=C(C(O)=O)C=C1 ZXAPQWICZVMRRE-UHFFFAOYSA-N 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 239000000543 intermediate Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86232706P | 2006-10-20 | 2006-10-20 | |
| PCT/SE2007/000924 WO2008048171A1 (en) | 2006-10-20 | 2007-10-19 | N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010506910A JP2010506910A (ja) | 2010-03-04 |
| JP2010506910A5 true JP2010506910A5 (enExample) | 2010-07-15 |
| JP4668346B2 JP4668346B2 (ja) | 2011-04-13 |
Family
ID=39314285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009533278A Expired - Fee Related JP4668346B2 (ja) | 2006-10-20 | 2007-10-19 | Ｎ−（２−ヒドロキシエチル）−ｎ−メチル−４−（キノリン−８−イル（１−（チアゾール−４−イルメチル）ピペリジン−４−イリデン）メチル）ベンズアミド、その製造方法、並びに疼痛、不安及びうつ病の治療のためのその使用 |
Country Status (32)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1641757A1 (en) * | 2003-05-16 | 2006-04-05 | AstraZeneca AB | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| MY148880A (en) * | 2006-10-20 | 2013-06-14 | Astrazeneca Ab | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression |
| JP2011520956A (ja) * | 2008-05-20 | 2011-07-21 | アストラゼネカ・アクチエボラーグ | 不安大うつ病性障害を処置する方法 |
| CN101906078B (zh) * | 2009-06-08 | 2012-02-01 | 上海威智医药科技有限公司 | 噻唑衍生物的合成方法 |
| CN102106807B (zh) * | 2009-12-29 | 2013-03-27 | 上海中西制药有限公司 | 一种固体制剂的制备方法及所得固体制剂 |
| PT3233825T (pt) * | 2014-12-19 | 2020-07-15 | Pharmnovo Ab | Derivados de diarilmetilideno-piperidina e sua utilização como agonistas do recetor opioide delta |
| EP3853435B1 (en) | 2018-09-21 | 2024-08-21 | Garland Industries, Inc. | Helical hardbanding |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| ATE306472T1 (de) * | 1997-12-24 | 2005-10-15 | Ortho Mcneil Pharm Inc | (4)-(aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden |
| US6492375B2 (en) * | 1998-06-30 | 2002-12-10 | Neuromed Technologies, Inc. | Partially saturated calcium channel blockers |
| SE9904673D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| WO2001046166A2 (en) | 1999-12-20 | 2001-06-28 | Neuromed Technologies, Inc. | Partially saturated calcium channel blockers |
| US6552036B2 (en) * | 2000-03-03 | 2003-04-22 | Ortho-Mcneil Pharmaceutical, Inc. | 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| SE0001208D0 (sv) * | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
| SE0101768D0 (sv) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| SE0300105D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof |
| SE0301442D0 (sv) | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations therof and uses thereof |
| SE0301444D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| EP1641757A1 (en) * | 2003-05-16 | 2006-04-05 | AstraZeneca AB | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0301445D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0301441D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| SE0400025D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| WO2005087742A1 (en) | 2004-03-08 | 2005-09-22 | Exelixis, Inc. | Metabolic kinase modulators and methods of use as pesticides |
| MY148880A (en) | 2006-10-20 | 2013-06-14 | Astrazeneca Ab | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression |
-
2007
- 2007-10-09 MY MYPI20091593A patent/MY148880A/en unknown
- 2007-10-18 TW TW096139052A patent/TW200826939A/zh unknown
- 2007-10-19 CL CL200703009A patent/CL2007003009A1/es unknown
- 2007-10-19 AT AT07835125T patent/ATE543818T1/de active
- 2007-10-19 MX MX2009003974A patent/MX2009003974A/es active IP Right Grant
- 2007-10-19 UY UY30652A patent/UY30652A1/es not_active Application Discontinuation
- 2007-10-19 WO PCT/SE2007/000924 patent/WO2008048171A1/en not_active Ceased
- 2007-10-19 HR HRP20120344TT patent/HRP20120344T1/hr unknown
- 2007-10-19 ES ES07835125T patent/ES2379519T3/es active Active
- 2007-10-19 AU AU2007313515A patent/AU2007313515B2/en not_active Ceased
- 2007-10-19 AR ARP070104641A patent/AR063345A1/es not_active Application Discontinuation
- 2007-10-19 CA CA2667041A patent/CA2667041C/en not_active Expired - Fee Related
- 2007-10-19 NZ NZ577060A patent/NZ577060A/en not_active IP Right Cessation
- 2007-10-19 RS RS20120166A patent/RS52260B/sr unknown
- 2007-10-19 PE PE2007001423A patent/PE20080892A1/es not_active Application Discontinuation
- 2007-10-19 SI SI200730905T patent/SI2079735T1/sl unknown
- 2007-10-19 DK DK07835125.1T patent/DK2079735T3/da active
- 2007-10-19 EP EP07835125A patent/EP2079735B1/en active Active
- 2007-10-19 CN CN2007800390975A patent/CN101528739B/zh not_active Expired - Fee Related
- 2007-10-19 US US11/875,014 patent/US7659286B2/en not_active Expired - Fee Related
- 2007-10-19 PT PT07835125T patent/PT2079735E/pt unknown
- 2007-10-19 PL PL07835125T patent/PL2079735T3/pl unknown
- 2007-10-19 KR KR1020097007893A patent/KR20090065534A/ko not_active Ceased
- 2007-10-19 RU RU2009111337/04A patent/RU2454414C2/ru not_active IP Right Cessation
- 2007-10-19 UA UAA200903085A patent/UA97648C2/ru unknown
- 2007-10-19 JP JP2009533278A patent/JP4668346B2/ja not_active Expired - Fee Related
- 2007-10-19 BR BRPI0717631-7A patent/BRPI0717631A2/pt not_active IP Right Cessation
- 2007-10-20 SA SA7280549A patent/SA07280549B1/ar unknown
-
2009
- 2009-03-26 IL IL197876A patent/IL197876A0/en unknown
- 2009-03-31 CO CO0903310009033100A patent/CO6180450A2/es not_active Application Discontinuation
- 2009-05-20 NO NO20091969A patent/NO20091969L/no not_active Application Discontinuation
- 2009-12-21 US US12/643,202 patent/US7977355B2/en not_active Expired - Fee Related
-
2010
- 2010-10-06 AU AU2010226996A patent/AU2010226996A1/en not_active Abandoned
-
2012
- 2012-04-25 CY CY20121100389T patent/CY1112718T1/el unknown
- 2012-07-24 PE PE2012001060A patent/PE20140634A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010506910A5 (enExample) | ||
| JP4187274B2 (ja) | 新規化合物、それらの使用および調製 | |
| JPWO2004046110A1 (ja) | メラニン凝集ホルモン受容体拮抗剤 | |
| US6878707B2 (en) | Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion | |
| JP2010538076A5 (enExample) | ||
| JP2008500337A5 (enExample) | ||
| JP2004503549A (ja) | 生体等配電子性ベンズアミド誘導体およびそのアポｂ−１００分泌阻害剤としての使用 | |
| JP2007519754A5 (enExample) | ||
| JP2005514373A5 (enExample) | ||
| AU2005272389B2 (en) | Novel cyclic aminobenzoic acid derivative | |
| HUP0302966A2 (hu) | Karboxamid-vegyületek és alkalmazásuk humán 11CBY receptor antagonistákként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| CA2909400C (en) | Dicarboxylic acid compound | |
| FR2842804A1 (fr) | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2011526594A5 (enExample) | ||
| CA2667041A1 (en) | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression | |
| JP2013503819A5 (enExample) | ||
| JP2008512470A5 (enExample) | ||
| JP2013543850A5 (enExample) | ||
| KR20130044240A (ko) | 페닐 카바메이트 화합물 및 이를 포함하는 근육 이완제 | |
| US20100179118A1 (en) | Cyclic aminoalkylcarboxamide derivative | |
| JP2012501344A (ja) | アミロイド症を治療する組成物及び方法 | |
| WO2008089436A3 (en) | Crystalline forms of histone deacetylase inhibitors | |
| JP2007520466A5 (enExample) | ||
| JP2005508382A5 (enExample) | ||
| CN108218947B (zh) | 一种含噻唑杂环的甾体衍生物及其制备方法与应用 |